About Aegis Science
Aegis Science is a company based in Nashville (United States) founded in 1986, and was acquired by Abry in February 2014. Drug testing and clinical laboratory services are provided. The company has 1,142 employees. Aegis Science has completed 2 acquisitions, including Ameritox and Diagnovus. Its website aegislabs.com draws about 16 thousand monthly visits.
Company details
Provider of drug testing and clinical laboratory services. It offers testing solutions for pain management, mental illness, substance use disorder, and sports. Services include adherence monitoring, clinical blood testing, and infectious disease testing. The company also provides analytical tools to track novel psychoactive substances. It maintains CLIA certification and other relevant accreditations, and offers clinical support and seamless EMR connectivity. Testing is available in oral fluid and urine.
- Headquarters Nashville, United States
- Employees 1,142
- Stage Acquired
- Website category Health · Addictions
- Email••••••••
- Website aegislabs.com
- Social LinkedIn Facebook
- Acquired by Abry (Feb 2014)
Funding Insights of Aegis Science
- Total Rounds 5
- Last Round Grant — $6.6M
- First Round $161,458
(Apr 2008)
- Investors Count 3
All 5 funding rounds of Aegis Science with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $6.6M | Grant | – | – | |
| Jun 2019 | Debt – Conventional | – | – | ||
| May 2018 | $350M | Debt – Conventional | – | – | – |
| Oct 2010 | Debt – Conventional | – | – | ||
| Apr 2008 | $161,458 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Aegis Science
Aegis Science has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Abry Partners and Crescent Capital BDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Metalmark Capital is focused on growth equity investments in middle-market companies. | metalmarkcapital.com | New York, United States | ||
Abry Partners is engaged in middle market private equity investments. | 1989 | abry.com | Boston, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Business development and investment management services are provided. | 2015 | crescentbdc.com | New York, United States |
Investor details for Aegis Science
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aegis Science
73 people are tracked at Aegis Science (19 in leadership, 54 in team); the tracked headcount is 1,142.
| Name | Role | Group |
|---|---|---|
Joel Galanter | Chief Legal Officer & General Counsel | Leadership |
Mike Ziegler | Chief Commercial Officer | Leadership |
David Priestley | CFO | Leadership |
Frank Basile | Chief Executive Officer | Leadership |
Kathy Sweeney | Director | Leadership |
Ken Whigham | Vice President, Laboratory Operations | Leadership |
Jason Asher | VP Of Business Applications | Leadership |
Wells Johnson | Senior Vice President, Legal & Chief Compliance Officer | Leadership |
Joshua Schrecker | Director, Clinical Affairs | Leadership |
Scott Folley | Director, Data Analytics And Middleware | Leadership |
David Schwope | Director, R&d And Scientific Affairs | Leadership |
Vicki Donnelly | Director | Leadership |
Kellie Schutzmann | Senior Vice President, Revenue Operations | Leadership |
Mary Neligan | Director Of Revenue Cycle Management Operations | Leadership |
Beverly Cawthon | Chief Operating Officer | Leadership |
Sarah Coble | Vice President, Strategy And Special Projects | Leadership |
Nick Hobbs | Vice President Of Managed Care | Leadership |
Rob Case | Vice President Of Software Engineering | Leadership |
Tim Ryan | Chief Information Officer | Leadership |
Hope Randle | Clinical Pharmacist | Team |
53 more people are available in the full profile.
Complete people profiles for Aegis Science
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aegis Science
Aegis Science has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Ameritox and Diagnovus.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pain medication monitoring solutions are provided for US clinicians. | ameritox.com | Baltimore, United States | 1996 | Mar 2018 | •••• | |
Molecular diagnostics for rare diseases are provided by Diagnovus. | diagnovus.com | Nashville, United States | 2011 | Jan 2015 | •••• |
Complete acquisition details for Aegis Science
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aegis Science
7 dated milestones of Aegis Science across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Aegis Science is founded.
- Funding First funding round of $161K.
- Exit Acquired by Metalmark Capital.
- Exit Acquired by Abry.
- Acquisition Acquires Diagnovus.
- Acquisition Acquires Ameritox.
- Funding Latest funding round, Grant, of $6.6M.
Web traffic of Aegis Science
The website of Aegis Science (aegislabs.com) receives about 16.4K visits a month and ranks #2,004,682 among all websites worldwide, #2,321 in Addictions.
- Monthly visits16.4K
▲ 5.7% vs previous month
- Unique visitors7K
per month
- Global rank#2,004,682
among all websites
- Category rank#2,321
Health · Addictions
- Bounce rate76%
- Pages per visit1.2
- Average visit2 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with Aegis Science. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
drugrecognition.com | drugrecognition.com | 100% | – | ||
drugfreeworkplaces.com | drugfreeworkplaces.com | 94% | #14,229,447 | – | |
ccm-drugtest.com | ccm-drugtest.com | 92% | – | ||
drugtesting.com | drugtesting.com | 90% | – | ||
wpcidrugfree.com | wpcidrugfree.com | 89% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Aegis Science
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aegis Science
Aegis Science was founded in 1986 and raised its 1st funding round 22 years after it was founded.
Aegis Science is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Aegis Science has 1,142 employees.
Provider of drug testing and clinical laboratory services. It offers testing solutions for pain management, mental illness, substance use disorder, and sports. Services include adherence monitoring, clinical blood testing, and infectious disease testing. The company also provides analytical tools to track novel psychoactive substances. It maintains CLIA certification and other relevant accreditations, and offers clinical support and seamless EMR connectivity. Testing is available in oral fluid and urine.
Aegis Science has 4 investors. Key investors include HHS, Abry Partners, Crescent Capital BDC, and Metalmark Capital.
Yes. Aegis Science was acquired by Abry in February 2014.